Literature DB >> 32461316

Better Viral Control despite Higher CD4+ T Cell Activation during Acute HIV-1 Infection in Zambian Women Is Linked to the Sex Hormone Estradiol.

Elina El-Badry1, Gladys Macharia2,3, Daniel Claiborne1, Kelsie Brooks1, Darío A Dilernia1, Paul Goepfert4, William Kilembe5, Susan Allen5,6,7, Jill Gilmour2,3, Eric Hunter8,7.   

Abstract

The influence of biological sex on disease progression in HIV-1-infected individuals has been focused on the chronic stage of infection, but little is known about how sex differences influence acute HIV-1 infection. We observed profound differences in viral load and CD4+ T cell activation from the earliest time points in men and women in a Zambian heterosexual acute infection cohort. Women exhibited a >2-fold higher rate of CD4+ T cell loss despite significantly lower viral loads (VL) than men. The importance of studying acute infection was highlighted by the observation that very early in infection, women exhibited significantly higher levels of CD4+ T cell activation, a difference that was lost over the first 3 years of infection as activation in men increased. In women, activation of CD4+ T cells in the acute phase was significantly correlated with plasma levels of 17β-estradiol (E2). However, unlike in men, higher CD4+ T cell activation in women was not associated with higher VL. In contrast, a higher E2 level in early infection was associated with lower early and set-point VL in women. We attribute this to an inhibitory effect of estradiol on virus replication, which we were able to observe with relevant transmitted/founder viruses in vitro Thus, estradiol plays a key role in defining major differences between men and women during early HIV-1 infection by contributing to both viral control and CD4+ T cell loss, an effect that extends into the chronic phase of the disease.IMPORTANCE Previous studies have identified sex-specific differences during chronic HIV-1 infection, but little is known about sex differences in the acute phase, or how disparities in the initial response to the virus may affect disease. We demonstrate that restriction of viral load in women begins during acute infection and is maintained into chronic infection. Despite this, women exhibit more rapid CD4+ T cell loss than men. These profound differences are influenced by 17β-estradiol, which contributes both to T cell activation and to reduced viral replication. Thus, we conclude that estradiol plays a key role in shaping responses to early HIV-1 infection that influence the chronic phase of disease.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  T cell activation; estrogen; human immunodeficiency virus; sex differences; viral load; viral pathogenesis; viral replication

Mesh:

Substances:

Year:  2020        PMID: 32461316      PMCID: PMC7394904          DOI: 10.1128/JVI.00758-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Imputation of data values that are less than a detection limit.

Authors:  Paul A Succop; Scott Clark; Mei Chen; Warren Galke
Journal:  J Occup Environ Hyg       Date:  2004-07       Impact factor: 2.155

Review 2.  SeXX matters in immunity.

Authors:  J G Markle; E N Fish
Journal:  Trends Immunol       Date:  2013-11-13       Impact factor: 16.687

3.  Sex Differences in Plasmacytoid Dendritic Cell Levels of IRF5 Drive Higher IFN-α Production in Women.

Authors:  Morgane Griesbeck; Susanne Ziegler; Sophie Laffont; Nikaïa Smith; Lise Chauveau; Phillip Tomezsko; Armon Sharei; Georgio Kourjian; Filippos Porichis; Meghan Hart; Christine D Palmer; Michael Sirignano; Claudia Beisel; Heike Hildebrandt; Claire Cénac; Alexandra-Chloé Villani; Thomas J Diefenbach; Sylvie Le Gall; Olivier Schwartz; Jean-Philippe Herbeuval; Brigitte Autran; Jean-Charles Guéry; J Judy Chang; Marcus Altfeld
Journal:  J Immunol       Date:  2015-10-30       Impact factor: 5.422

4.  A restriction enzyme based cloning method to assess the in vitro replication capacity of HIV-1 subtype C Gag-MJ4 chimeric viruses.

Authors:  Daniel T Claiborne; Jessica L Prince; Eric Hunter
Journal:  J Vis Exp       Date:  2014-08-31       Impact factor: 1.355

5.  Multiplexed highly-accurate DNA sequencing of closely-related HIV-1 variants using continuous long reads from single molecule, real-time sequencing.

Authors:  Dario A Dilernia; Jung-Ting Chien; Daniela C Monaco; Michael P S Brown; Zachary Ende; Martin J Deymier; Ling Yue; Ellen E Paxinos; Susan Allen; Alfredo Tirado-Ramos; Eric Hunter
Journal:  Nucleic Acids Res       Date:  2015-06-22       Impact factor: 16.971

6.  Longitudinal human immunodeficiency virus type 1 load in the italian seroconversion study: correlates and temporal trends of virus load.

Authors:  C M Lyles; M Dorrucci; D Vlahov; P Pezzotti; G Angarano; A Sinicco; F Alberici; T M Alcorn; S Vella; G Rezza
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

Review 7.  Sex affects immunity.

Authors:  Leesa M Pennell; Carole L Galligan; Eleanor N Fish
Journal:  J Autoimmun       Date:  2012-01-04       Impact factor: 7.094

8.  The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor α signaling.

Authors:  Cyril Seillet; Sophie Laffont; Florence Trémollières; Nelly Rouquié; Claude Ribot; Jean-François Arnal; Victorine Douin-Echinard; Pierre Gourdy; Jean-Charles Guéry
Journal:  Blood       Date:  2011-11-16       Impact factor: 22.113

9.  Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations.

Authors:  Kristen L Phiel; Ruth A Henderson; Steven J Adelman; M Merle Elloso
Journal:  Immunol Lett       Date:  2005-02-15       Impact factor: 3.685

10.  CD4 counts and viral loads of newly diagnosed HIV-infected individuals: implications for treatment as prevention.

Authors:  Sarishen Govender; Kennedy Otwombe; Thandekile Essien; Ravindre Panchia; Guy de Bruyn; Lerato Mohapi; Glenda Gray; Neil Martinson
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

View more
  4 in total

1.  Sex differences in cytokine profiles during suppressive antiretroviral therapy.

Authors:  Christophe Vanpouille; Alan Wells; Timothy Wilkin; Jyoti S Mathad; Sheldon Morris; Leonid Margolis; Sara Gianella
Journal:  AIDS       Date:  2022-05-25       Impact factor: 4.632

2.  Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial.

Authors:  Eileen P Scully; Evgenia Aga; Athe Tsibris; Nancie Archin; Kate Starr; Qing Ma; Gene D Morse; Kathleen E Squires; Bonnie J Howell; Guoxin Wu; Lara Hosey; Scott F Sieg; Lynsay Ehui; Francoise Giguel; Kendyll Coxen; Curtis Dobrowolski; Monica Gandhi; Steve Deeks; Nicolas Chomont; Elizabeth Connick; Catherine Godfrey; Jonathan Karn; Daniel R Kuritzkes; Ronald J Bosch; Rajesh T Gandhi
Journal:  Clin Infect Dis       Date:  2022-10-12       Impact factor: 20.999

Review 3.  HIV Pathogenesis in the Human Female Reproductive Tract.

Authors:  Marta Rodriguez-Garcia; Kaleigh Connors; Mimi Ghosh
Journal:  Curr HIV/AIDS Rep       Date:  2021-03-15       Impact factor: 5.495

Review 4.  Sex differences in HIV-1 persistence and the implications for a cure.

Authors:  Shringar Rao
Journal:  Front Glob Womens Health       Date:  2022-09-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.